Research ArticleRheumatoid Arthritis
Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial
Mai T.T. Nguyen, Hanne Lindegaard, Oliver Hendricks, Charlotte Sværke Jørgensen, Bjørn Kantsø and Nina Friis-Møller
The Journal of Rheumatology December 2017, 44 (12) 1794-1803; DOI: https://doi.org/10.3899/jrheum.161407
Mai T.T. Nguyen
From the Department of Infectious Diseases, and Department of Rheumatology, and Odense Patient data Explorative Network (OPEN), Odense University Hospital; Institute of Clinical Research, University of Southern Denmark; Institute of Regional Research, University of Southern Denmark, Odense; Department of Rheumatology, King Christian Xth Hospital for Rheumatic Disease, Graasten; Department of Microbiology and Virology, Statens Serum Institut, Copenhagen; Unit of Infectious Diseases, Department of Internal Medicine, Zealand University Hospital, Roskilde,
Denmark.
Hanne Lindegaard
Oliver Hendricks
Charlotte Sværke Jørgensen
Bjørn Kantsø
Data supplements
Data Supplement
Files in this Data Supplement:
In this issue
The Journal of Rheumatology
Vol. 44, Issue 12
1 Dec 2017
Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial
Mai T.T. Nguyen, Hanne Lindegaard, Oliver Hendricks, Charlotte Sværke Jørgensen, Bjørn Kantsø, Nina Friis-Møller
The Journal of Rheumatology Dec 2017, 44 (12) 1794-1803; DOI: 10.3899/jrheum.161407
Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial
Mai T.T. Nguyen, Hanne Lindegaard, Oliver Hendricks, Charlotte Sværke Jørgensen, Bjørn Kantsø, Nina Friis-Møller
The Journal of Rheumatology Dec 2017, 44 (12) 1794-1803; DOI: 10.3899/jrheum.161407